paxilline has been researched along with Ameloblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alabdulaali, NA; AlFouzan, NF; Alrabeeah, MA; Bello, IO; Nieminen, P | 1 |
1 other study(ies) available for paxilline and Ameloblastoma
| Article | Year |
|---|---|
FAK, paxillin, and PI3K in ameloblastoma and adenomatoid odontogenic tumor.
Topics: Ameloblastoma; Focal Adhesion Kinase 1; Humans; Odontogenic Tumors; Paxillin; Phosphatidylinositol 3-Kinases | 2021 |